"NovogeneAIT Genomics Singapore...has entered into a research collaboration with A*STAR’s Institute of Molecular and Cell Biology (IMCB). This collaboration aims to elucidate the understanding of immune checkpoint inhibitors and their effects on various cancers using spatial transcriptomics technologies."